Industry Leaders

61. 3 Keys To Successful Industry-Academic Collaborations 2/1/2016

    Industry-academic collaborations are becoming more popular as pharmaceutical and biotechnology companies seek to harness the innovation and human capital within life sciences institutions.

62. How Lab Improvements Can Drive Productivity 2/1/2016

    Today’s laboratory managers are facing significant budget cuts while simultaneously being challenged to obtain faster results. These pressures have created an increased focus on identifying potential areas of lab productivity improvement.

63. Strategic Financing Alternatives For Later-Stage Companies 1/1/2016

    With the exception of several mega-financings for blue chip management teams in companies such as Juno and Denali from syndicates of well-heeled venture funds such as ARCH Ventures and Flagship Ventures, venture financing for startup life science companies has been relatively lean for the last several years.

64. Should Your Executives Help You Recruit? 1/1/2016

    No industry is more competitive than the life sciences for leadership talent. And we all know there are obvious advantages to asking one’s own leaders to help recruit, but allow me to offer a few words of caution if this is your strategy.

65. How Much Transparency Is Too Much With Clinical Trials? 11/1/2015

    There is a growing movement by some researchers and regulators to increase disclosure of clinical trial results.

66. A Life Science Manufacturing Executive's Role In Establishing A Quality Culture 11/1/2015

    Creating the appropriate quality culture is arguably the most important element of being a manufacturing leader in the life sciences industry. Yet, reflecting back on my long career, I have not seen a single recipe for doing this, and I don’t profess to have a well-documented approach myself. But, boy, do I have some stories.

67. Does Pharma Demand Forecasting Keep You Awake At Night? 10/1/2015

    Given the uniquely long and winding road pharmaceuticals must take to market, it is difficult for developers to predict the manufacturing capacity they will need when their product finally gets there.

68. The Challenges Surrounding Immunology 10/1/2015

    Immunotherapy is a growing trend within the oncology industry, as the traditional processes, methods, and equipment used in the fight against cancer are evolving and adapting constantly in order to try to find the most effective cure. Traditional treatments like chemotherapy and radiation remain effective methods of fighting the disease; however, recent research has started to shift away from aggressive indiscriminate treatments toward more targeted therapies.

69. Quality In The Biologics Discovery And Development Continuum 9/1/2015

    With biologics filling the pipelines of life sciences companies more than ever, the industry needs to rethink its view toward quality. Once primarily considered a focus in downstream drug development and manufacturing, the issue of quality now demands attention in upstream discovery research as well. In fact, the line between discovery and development in biologics looks more like the intersection of a Venn diagram than a line at all, with discovery and development sharing space in the drug development quality continuum.

70. How Serialization Can Help Your Pharma Brand 9/1/2015

    By now you probably know that serialization is your best option for combatting counterfeit pharmaceuticals. Unfortunately, you probably also understand that developing and implementing a serialization plan is no simple task. Your packaging, warehousing, and supply chain processes all will be altered, which involves a lot of change management for any organization. The primary goal, of course, is safe and secure drugs for patients, and yes, regulatory compliance is part of the equation. But many people underestimate the additional positive effect serialization can have on a company’s brand.